The Pharmaceuticals in Dosage market size value per capita in Malaysia witnessed considerable fluctuations from 2012 to 2022. Starting from 2012 at 88.52 USD per capita, the value saw its first peak in 2014 at 98.63 USD, followed by a notable drop to 82.55 USD in 2017. From there, a significant upward trend is observed, culminating in a peak value of 117.9 USD per capita in 2021. This was followed by a slight decline to 108.67 USD in 2022.
Year-on-year variations indicated:
- The last two years (2021-2022): A decrease of approximately -7.8%.
- The last five years showed a CAGR of approximately +4.4%, reflecting a moderate average annual growth rate since 2017.
Future trends to watch for include the impact of aging population demographics, increasing healthcare spending, potential regulatory changes, and the ongoing effects of global supply chain adjustments. Additionally, technological advancements in pharmaceutical development and distribution could further shape the per capita market size in upcoming years.
How does Malaysia rank in Pharmaceuticals in Dosage Market Size Value Per Capita?
| # | 59 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 1,580 | 2023 | View data | ||
| 2 | 2 Germany | 1,460 | 2023 | View data | ||
| 3 | 3 Denmark | 1,300 | 2023 | View data | ||
| 4 | 4 Iceland | 1,220 | 2023 | View data | ||
| 5 | 5 Norway | 1,070 | 2023 | View data | ||
| 37 | 37 South Africa | 117.86 | 2023 | View data | ||
| 38 | 38 Brazil | 115.83 | 2023 | View data | ||
| 39 | 39 Malaysia | 114.42 | 2023 | |||
| 40 | 40 Belarus | 112.6 | 2023 | View data | ||
| 41 | 41 Peru | 82.62 | 2023 | View data | ||
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
